SABESP (NYSE: SBS): Essential Water Services for Brazil’s Economic Core
SABESP is Brazil’s largest water and wastewater utility, providing essential services to residential, commercial, and industrial customers across São Paulo.
info@marketfacts.ca +1-807 788 8478
SABESP is Brazil’s largest water and wastewater utility, providing essential services to residential, commercial, and industrial customers across São Paulo.
QFIN operates a technology-enabled consumer lending platform in China, connecting borrowers with financial institutions while using proprietary risk models for credit assessment and loan management.
Plug Power is a hydrogen-focused energy company developing fuel cells, hydrogen production, storage, and distribution solutions, primarily targeting material handling, mobility, and stationary power markets
TaskUs provides outsourced digital services focused on customer support, content moderation, trust & safety, and AI operations for fast-growing, tech-centric companies.
Pediatrix is one of the largest physician-led medical groups in the U.S., specializing in care for newborns, mothers, and pediatric patients, primarily in hospital-based settings.
Algonquin Power & Utilities Corp. owns and operates regulated electric, gas, and water utilities, alongside a portfolio of renewable power generation assets across North America and select international markets.
Universal Insurance Holdings is an integrated U.S. insurance holding company focused on personal residential insurance products, including homeowners, renters, condo unit owners, dwelling & fire coverage, and allied lines. The business encompasses underwriting, policy administration, claims, actuarial, and reinsurance management, plus a digital agency platform.
Ameresco, Inc. provides energy solutions in the United States, Canada and Europe. It operates through North America Regions, U.S. Federal, Renewable Fuels, Europe, and all other segments.
ASIX engages in the manufacture and sale of polymer resins in the United States and internationally.
CPRX a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.